Mucormycosis risk mitigation in the COVID battle

News Today 14.05.2021

The new fear after the treatment of COVID-19, especially in an ICU setting, is contracting a severe disease known as mucormycosis. This is a serious, but rare, fungal infection caused by a group of fungi known as mucormycetes. Mucormycosis usually affects people who have poor immunity, and those with uncontrolled diabetes have the highest risk of developing it. Other risk factors of mucormycosis include steroid treatment, those who have malignancies, HIV/AIDS and those who have been treated with medicines such as deferoxamine for iron overload conditions. (Read More)

Bookmark

Be the first to comment

Leave a Reply

Your email address will not be published.


*